Optimizerx Corp (OPRX)

Dec 23, 2024, 8:45 AM EST - 25 days ago

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

Nov 18, 2024, 7:30 AM EST - 2 months ago

OptimizeRx to Participate in Upcoming Investor Conferences

Nov 13, 2024, 10:58 PM EST - 2 months ago

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 2 months ago

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

Sep 10, 2024, 7:30 AM EDT - 4 months ago

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

Sep 9, 2024, 12:00 PM EDT - 4 months ago

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

Aug 8, 2024, 8:06 PM EDT - 5 months ago

OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 7:30 AM EDT - 6 months ago

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

Jul 23, 2024, 7:30 AM EDT - 6 months ago

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

Jul 15, 2024, 7:30 AM EDT - 6 months ago

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

Jun 20, 2024, 7:30 AM EDT - 7 months ago

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

May 14, 2024, 11:21 PM EDT - 8 months ago

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:01 PM EDT - 8 months ago

OptimizeRx Reports First Quarter 2024 Financial Results

Apr 26, 2024, 7:30 AM EDT - 9 months ago

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

Apr 18, 2024, 7:30 AM EDT - 9 months ago

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

Apr 16, 2024, 7:00 AM EDT - 9 months ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

Apr 11, 2024, 7:30 AM EDT - 10 months ago

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

Mar 28, 2024, 11:20 AM EDT - 10 months ago

OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript

Mar 25, 2024, 7:30 AM EDT - 10 months ago

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

Mar 11, 2024, 4:30 PM EDT - 11 months ago

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

Mar 4, 2024, 3:51 PM EST - 11 months ago

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort

Jan 25, 2024, 7:30 AM EST - 1 year ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Jan 9, 2024, 7:30 AM EST - 1 year ago

OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update

Dec 18, 2023, 7:30 AM EST - 1 year ago

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

Nov 6, 2023, 11:48 AM EST - 1 year ago

OptimizeRx Corporation (OPRX) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 7:00 AM EST - 1 year ago

OptimizeRx Reports Third Quarter 2023 Financial Results

Oct 25, 2023, 7:30 AM EDT - 1 year ago

OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET

Oct 12, 2023, 7:00 AM EDT - 1 year ago

OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers

Aug 24, 2023, 8:00 AM EDT - 1 year ago

OptimizeRx Expands AI Powered Omnichannel Platform

Aug 14, 2023, 6:54 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:01 PM EDT - 1 year ago

OptimizeRx Reports Second Quarter 2023 Financial Results

Jul 31, 2023, 8:01 AM EDT - 1 year ago

OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET

Jul 21, 2023, 1:47 PM EDT - 1 year ago

OptimizeRx Aims For Growth After Swoon

May 24, 2023, 7:30 AM EDT - 1 year ago

OptimizeRx's CEO Provides 2023 Midyear Strategic Update

May 18, 2023, 8:01 AM EDT - 1 year ago

OptimizeRx's Karina Castagna Named One of the 2023 PM360 ELITE 100

May 10, 2023, 10:44 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:01 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2023 Financial Results

Apr 4, 2023, 8:01 AM EDT - 1 year ago

OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report

Apr 3, 2023, 5:16 PM EDT - 1 year ago

OptimizeRx Has A Good Growth Path Ahead

Mar 29, 2023, 9:20 AM EDT - 1 year ago

Financial Times Ranks OptimizeRx Amongst The Americas' Fastest Growing Companies for the Fourth Consecutive Year

Mar 14, 2023, 8:02 AM EDT - 2 years ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)

AHCO CARA TKNO

Mar 14, 2023, 7:30 AM EDT - 2 years ago

OptimizeRx Authorizes $15 Million Share Repurchase Program

Mar 9, 2023, 8:01 AM EST - 2 years ago

OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients

Mar 8, 2023, 10:23 PM EST - 2 years ago

OptimizeRx Corporation (OPRX) Q4 2022 Earnings Call Transcript

Mar 8, 2023, 4:01 PM EST - 2 years ago

OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 23, 2023, 8:00 AM EST - 2 years ago

OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET

Feb 9, 2023, 8:30 AM EST - 2 years ago

OptimizeRx's Karina Castagna Named to MM+M's 40 Under 40 List of the Medical Marketing Industry's Brightest Young Stars

Jan 4, 2023, 7:30 AM EST - 2 years ago

OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference

Nov 9, 2022, 12:56 AM EST - 2 years ago

OptimizeRx Corporation (OPRX) Q3 2022 Earnings Call Transcript

Nov 8, 2022, 4:01 PM EST - 2 years ago

OptimizeRx Reports Third Quarter 2022 Financial Results